Thrilled to share that Neoclease has won the Golden Ticket from LabCentral Ignite! 🎉 Huge thanks for the incredible support as we continue to push the boundaries of precision gene editing with AI-powered innovation. 🔬✨ Exciting times ahead! 💡 #Biotech #AI #PrecisionMedicine #Innovation #FutureOfHealth #biotech #AI #precisionmedicine
Last night, we proudly hosted our 4th annual LabCentral Ignite #GoldenTicket Contest, and we’re excited to introduce this year’s winners! Six rockstar #biotechstartups took home the prize: three from the #FoundersofColor category—Interon Laboratories, Inc., PhagePro, and Nanoplex LLC—and three from the #WomenFounders category—Neoclease, Lybra Bio, and Coagulo Medical Technologies, Inc.. A huge congratulations to all! 🙌 🎉 Designed to uplift and celebrate companies led by underrepresented communities in the #biotech industry, Ignite golden tickets award startups with $50,000 in funding for space at LabCentral and access to the Ignite Golden Ticket fellowship, which provides them with the network, resources and support needed to succeed in the industry. A special thank you to our sponsors for helping make this opportunity possible: Bayer, Bristol Myers Squibb, Eli Lilly and Company, Novartis, Pfizer, Takeda, BioMarin Pharmaceutical Inc., Silicon Valley Bank, a division of First Citizens Bank, Wilson Sonsini Goodrich & Rosati, and EisnerAmper.